Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Curis Inc (CRIS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 113,310
  • Shares Outstanding, K 163,980
  • Annual Sales, $ 7,530 K
  • Annual Income, $ -60,410 K
  • 36-Month Beta 1.63
  • Price/Sales 11.00
  • Price/Cash Flow N/A
  • Price/Book 3.77
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.40
  • Most Recent Earnings -0.11 on 11/07/17
  • Next Earnings Date 03/08/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.67 +11.94%
on 01/18/18
0.82 -8.54%
on 01/16/18
unch (unch)
since 12/22/17
3-Month
0.67 +11.94%
on 01/18/18
1.74 -56.90%
on 10/24/17
-0.82 (-52.23%)
since 10/23/17
52-Week
0.67 +11.94%
on 01/18/18
3.22 -76.71%
on 03/10/17
-1.83 (-70.93%)
since 01/23/17

Most Recent Stories

More News
Curis Announces Initiation of Phase 1 Trial of CA-4948, a Small Molecule Inhibitor of IRAK4 Kinase in Patients with Lymphoma

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today announced initiation of...

CRIS : 0.75 (+8.54%)
Developments in the Biotech and Pain Management Therapeutics Segments

According to a report by Grand View Research, Inc. the global biotechnology market is expected to reach USD 727.1 billion by 2025. Major technological advancements in segments such as regenerative medicine...

TRVN : 1.77 (+1.14%)
BICX : 0.2400 (unch)
DRRX : 1.25 (unch)
CRIS : 0.75 (+8.54%)
EGLT : 1.04 (+4.00%)
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Loncar Investments, LLC today announced the result of the semi-annual rebalance and reconstitution of the Loncar Cancer Immunotherapy Index, a stock index of the top 30 companies developing...

ADXS : 3.06 (+1.66%)
CNCR : 28.70 (+2.57%)
CRIS : 0.75 (+8.54%)
IDRA : 2.16 (-0.46%)
SNDX : 10.49 (-3.05%)
NKTR : 77.79 (+1.32%)
PIRS : 7.43 (-0.67%)
Curis Announces Upcoming Presentation at the American Society of Hematology 59th Annual Meeting & Exposition

Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today announced an upcoming presentation...

CRIS : 0.75 (+8.54%)
Curis Reports Third Quarter 2017 Financial Results

Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers, reported today its financial...

CRIS : 0.75 (+8.54%)
Curis, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 7, 2017 / Curis, Inc. (NASDAQ: CRIS) will be discussing their earnings results in their Q3 Earnings Call to be held on November 7, 2017 at 8:30 AM Eastern Time.

CRIS : 0.75 (+8.54%)
Curis, Upcoming SITC Meeting, Aurigene Collaboration and Analysts Review

NEW YORK, NY / ACCESSWIRE / November 6, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive...

CRIS : 0.75 (+8.54%)
Curis to Present at the Society for Immunotherapy of Cancer 32nd Annual Meeting and the Cowen IO NEXT Summit

Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today announced upcoming presentations...

CRIS : 0.75 (+8.54%)
Biotech Stocks on Investors' Radar -- Curis, Egalet, Esperion Therapeutics, and GlycoMimetics

If you want a Stock Review on CRIS, EGLT, ESPR, or GLYC then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. On Wednesday, November 01, 2017, US markets...

ESPR : 80.76 (+3.63%)
CRIS : 0.75 (+8.54%)
EGLT : 1.04 (+4.00%)
GLYC : 23.94 (+3.15%)
Curis to Release Third Quarter 2017 Financial Results and Hold Conference Call on November 7, 2017

Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today announced that the Company will...

CRIS : 0.75 (+8.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration. Curis' product development involves the use of small molecules or proteins to modulate...

See More

Key Turning Points

2nd Resistance Point 0.81
1st Resistance Point 0.78
Last Price 0.75
1st Support Level 0.70
2nd Support Level 0.65

See More

52-Week High 3.22
Fibonacci 61.8% 2.25
Fibonacci 50% 1.95
Fibonacci 38.2% 1.64
Last Price 0.75
52-Week Low 0.67

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.